Bell Asset Management’s Gilead Sciences GILD Stock Holding History

Bell Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-58,643	Closed	-$3.81M	–	67
2019 Q4	$3.81M	Sell	58,643 -47,521	-45%	-$3.09M	0.98%	57
2019 Q3	$6.73M	Buy	106,164 +35,755	+51%	+$2.34M	1.03%	53
2019 Q2	$4.76M	Hold	70,409	–	–	0.77%	61
2019 Q1	$4.58M	Buy	70,409 +4,135	+6%	+$275K	0.79%	58
2018 Q4	$4.14M	Buy	66,274 +7,973	+14%	+$557K	0.87%	57
2018 Q3	$4.5M	Buy	58,301 +4,209	+8%	+$318K	0.94%	59
2018 Q2	$3.84M	Buy	54,092 +493	+0.9%	+$34.8K	0.93%	57
2018 Q1	$5.27M	Hold	53,599	–	–	1.05%	56
2017 Q4	$3.84M	Buy	+53,599	New	+$4.07M	0.92%	60

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bell Asset Management's GILD Position: Q1 2020 in Review

Bell Asset Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 58,643 shares — an estimated $3.81M sold.

Bell Asset Management first reported a position in GILD in Q4 2017 and held it in 9 quarters. The position peaked at $6.73M in Q3 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

Bell Asset Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
Bell Asset Management sold 58,643 Gilead Sciences shares in Q1 2020, an estimated $3.81M.
Bell Asset Management first reported a position in Gilead Sciences in Q4 2017 and held it in 9 quarters.
Bell Asset Management's Gilead Sciences position peaked at $6.73M in Q3 2019.
1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Bell Asset Management's 13F filing for Q1 2020, filed 14 May 2020.